|
|
AlT4 |
|
Vaxjo ID |
122 |
|
Vaccine Adjuvant Name |
AlT4 |
|
Adjuvant VO ID |
VO_0005299
|
|
Description |
combination adjuvant with TLR4 receptor that induces Th1/Th2 response |
|
Stage of Development |
Research |
|
Location Licensed |
PAI Life Sciences in Seattle, WA |
|
Host Species for Testing |
Mouse |
|
Storage |
2-8C |
|
Function |
Type: combination vaccine adjuvant. Target receptor: Toll-like receptor 4 (TLR4). Induces Th1/Th2 mixed immune profile. |
| References |
(Carter, 2021): Vaccine Adjuvant Compendium (VAC) [https://vac.niaid.nih.gov/view?id=19]
|
|
